JNBA Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Sell
8,092
-551
-6% -$14.7K 0.02% 180
2025
Q4
$215K Buy
8,643
+608
+8% +$15.3K 0.02% 182
2025
Q3
$205K Hold
8,035
0.02% 179
2025
Q2
$195K Buy
8,035
+120
+2% +$2.8K 0.02% 181
2025
Q1
$201K Hold
7,915
0.02% 176
2024
Q4
$210K Sell
7,915
-127
-2% -$3.44K 0.02% 174
2024
Q3
$233K Sell
8,042
-3,440
-30% -$100K 0.02% 174
2024
Q2
$321K Sell
11,482
-1,538
-12% -$42.3K 0.03% 154
2024
Q1
$361K Sell
13,020
-265
-2% -$7.35K 0.04% 154
2023
Q4
$382K Sell
13,285
-76
-0.6% -$2.3K 0.04% 152
2023
Q3
$443K Sell
13,361
-160
-1% -$5.66K 0.06% 132
2023
Q2
$496K Buy
13,521
+443
+3% +$17.2K 0.06% 128
2023
Q1
$534K Buy
13,078
+15
+0.1% +$648 0.07% 126
2022
Q4
$669K Sell
13,063
-3,284
-20% -$157K 0.09% 117
2022
Q3
$715K Buy
16,347
+1,072
+7% +$52.1K 0.11% 107
2022
Q2
$801K Sell
15,275
-190
-1% -$9.68K 0.12% 97
2022
Q1
$801K Sell
15,465
-1,526
-9% -$79.2K 0.11% 102
2021
Q4
$1M Buy
16,991
+304
+2% +$15.1K 0.12% 93
2021
Q3
$718K Hold
16,687
0.1% 106
2021
Q2
$653K Buy
16,687
+1,226
+8% +$47.7K 0.09% 107
2021
Q1
$560K Buy
15,461
+57
+0.4% +$2.02K 0.08% 109
2020
Q4
$567K Sell
15,404
-391
-2% -$14.3K 0.09% 103
2020
Q3
$550K Sell
15,795
-86
-0.5% -$3.02K 0.11% 93
2020
Q2
$493K Sell
15,881
-139
-0.9% -$4.72K 0.11% 95
2020
Q1
$496K Buy
16,020
+199
+1% +$6.78K 0.12% 90
2019
Q4
$588K Buy
15,821
+777
+5% +$27.7K 0.11% 92
2019
Q3
$513K Sell
15,044
-342
-2% -$12.4K 0.1% 94
2019
Q2
$632K Buy
15,386
+552
+4% +$21.9K 0.13% 88
2019
Q1
$598K Buy
14,834
+5,629
+61% +$225K 0.13% 85
2018
Q4
$381K Sell
9,205
-112,487
-92% -$4.67M 0.09% 98
2018
Q3
$5.09M Buy
121,692
+112,487
+1,222% +$4.33M 2.28% 4
2018
Q2
$317K Buy
9,205
+2,357
+34% +$80.5K 0.07% 106
2018
Q1
$231K Hold
6,848
0.05% 116
2017
Q4
$235K Hold
6,848
0.05% 117
2017
Q3
$232K Hold
6,848
0.05% 108
2017
Q2
$218K Sell
6,848
-271
-4% -$8.55K 0.05% 110
2017
Q1
$231K Sell
7,119
-105
-1% -$3.31K 0.05% 108
2016
Q4
$223K Sell
7,224
-20,181
-74% -$616K 0.05% 110
2016
Q3
$881K Buy
27,405
+20,272
+284% +$678K 0.13% 56
2016
Q2
$238K Sell
7,133
-132
-2% -$4.21K 0.07% 102
2016
Q1
$204K Sell
7,265
-79
-1% -$2.26K 0.07% 98
2015
Q4
$225K Hold
7,344
0.09% 95
2015
Q3
$219K Hold
7,344
0.09% 88
2015
Q2
$234K Hold
7,344
0.09% 91
2015
Q1
$242K Sell
7,344
-1,183
-14% -$37.6K 0.09% 88
2014
Q4
$252K Hold
8,527
0.1% 85
2014
Q3
$239K Buy
8,527
+1,486
+21% +$41.7K 0.11% 84
2014
Q2
$198K Buy
7,041
+738
+12% +$21K 0.1% 89
2014
Q1
$192K Buy
6,303
+410
+7% +$12.2K 0.1% 84
2013
Q4
$171K Buy
5,893
+111
+2% +$3.23K 0.09% 91
2013
Q3
$158K Buy
5,782
+485
+9% +$13.2K 0.1% 91
2013
Q2
$141K Buy
+5,297
New +$146K 0.1% 95

Other funds holding PFE

JNBA Financial Advisors's PFE Position: Q1 2026 in Review

JNBA Financial Advisors reduced its Pfizer (PFE) stake by 6.4% in Q1 2026, selling an estimated $14.7K and leaving 8,092 shares worth $227K. The position accounts for 0.02% of the portfolio, ranked #180.

JNBA Financial Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.09M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • JNBA Financial Advisors held 8,092 shares of Pfizer worth $227K as of Q1 2026.
  • JNBA Financial Advisors sold 551 Pfizer shares in Q1 2026, an estimated $14.7K.
  • Pfizer made up 0.02% of JNBA Financial Advisors's portfolio in Q1 2026, its #180 holding.
  • JNBA Financial Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • JNBA Financial Advisors's Pfizer position peaked at $5.09M in Q3 2018.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.